Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Sichuan Huiyu Pharmaceutical Wins Marketing Approvals in Italy, Portugal, Saudi Arabia
March 27, 2025
Company
Deals
Merck KGaA Partners with Roche to Commercialize Tepmetko in China
March 26, 2025
Company
Hospital
China Resources Medical Holdings Reports 2024 Revenue of RMB9.86 Billion Amid Net Profit Surge
March 26, 2025
Company
Drug
GSK’s Blujepa Approved by FDA for Uncomplicated Urinary Tract Infections
March 26, 2025
Company
Drug
Guangzhou Doublle Bioproduct Receives IND Approval for E101 in Type 2 Diabetes
March 26, 2025
Company
WuXi Biologics Reports 9.6% Revenue Growth in 2024, Expanding CRDMO Services
March 26, 2025
Company
Drug
Sanofi’s Tolebrutinib Accepted for FDA Review in Non-Relapsing Secondary Progressive Multiple Sclerosis
March 26, 2025
Company
Fosun Pharma’s 2024 Revenue Reaches RMB 41.1 Billion Amid R&D Investment
March 26, 2025
Company
Burning Rock Reports Q4 Revenue Growth Amid Improved Profitability
March 26, 2025
Policy / Regulatory
China’s 2025 Pharmacopoeia Edition Approved, Set for October 1 Implementation
March 26, 2025
Company
Alphamab Oncology Reports 192.58% Revenue Surge Led by Envafolimab
March 26, 2025
Company
Drug
Shanghai Henlius Biotech Receives NMPA Approval for HLX79 in Glomerulonephritis Trial
March 26, 2025
1
2
…
209
210
211
212
213
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
